| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ankyrin binding | 2.38e-05 | 23 | 49 | 3 | GO:0030506 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 5.28e-05 | 5 | 48 | 2 | GO:2000373 | |
| GeneOntologyBiologicalProcess | regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 5.28e-05 | 5 | 48 | 2 | GO:2000371 | |
| GeneOntologyBiologicalProcess | positive regulation of isomerase activity | 1.11e-04 | 7 | 48 | 2 | GO:0010912 | |
| GeneOntologyBiologicalProcess | regulation of isomerase activity | 1.11e-04 | 7 | 48 | 2 | GO:0010911 | |
| GeneOntologyBiologicalProcess | positive regulation of ATP-dependent activity | 1.57e-04 | 45 | 48 | 3 | GO:0032781 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.47e-04 | 114 | 49 | 4 | GO:0016528 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | DNAJB11 FAM120A AKAP8 STRAP RBBP4 CALU RBM10 SIPA1L3 CDC42 YWHAE HNRNPU | 3.63e-09 | 714 | 49 | 11 | 28302793 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NAMPT FAM120A ZNF280D STRAP RBBP4 CALU ELP1 UHRF1 CHD1 PRMT3 CDC42 YWHAE HNRNPU | 5.75e-08 | 1425 | 49 | 13 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DNAJB11 AKAP8 RBBP4 RBM10 CPNE3 ELP1 UHRF1 CHD1 YWHAE HNRNPU ITPR2 | 1.43e-07 | 1024 | 49 | 11 | 24711643 |
| Pubmed | NAMPT FAM120A AKAP8 KHDRBS3 STRAP RBBP4 SIPA1L3 ELP1 UHRF1 DDX3Y YWHAE SHC3 | 3.20e-07 | 1371 | 49 | 12 | 36244648 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 5.22e-07 | 701 | 49 | 9 | 30196744 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.37e-07 | 212 | 49 | 6 | 33853758 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 5.41e-07 | 704 | 49 | 9 | 29955894 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DNAJB11 NAMPT STRAP RBBP4 UBE3A CALU ELP1 PRMT3 CDC42 PPID YWHAE HNRNPU | 6.02e-07 | 1455 | 49 | 12 | 22863883 |
| Pubmed | 8.24e-07 | 122 | 49 | 5 | 30773093 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 9.09e-07 | 232 | 49 | 6 | 25515538 | |
| Pubmed | 9.61e-07 | 551 | 49 | 8 | 34728620 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FAM120A AKAP8 STRAP RBBP4 SIPA1L3 CPNE3 LAMA3 CDC42 YWHAE HNRNPU ITPR2 | 1.08e-06 | 1257 | 49 | 11 | 36526897 |
| Pubmed | 1.83e-06 | 601 | 49 | 8 | 33658012 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJB11 NAMPT FAM120A RBBP4 UBE3A CPNE3 ELP1 CHD1 PRMT3 YWHAE HNRNPU | 2.22e-06 | 1353 | 49 | 11 | 29467282 |
| Pubmed | 2.38e-06 | 274 | 49 | 6 | 34244482 | ||
| Pubmed | 2.48e-06 | 847 | 49 | 9 | 35850772 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.48e-06 | 626 | 49 | 8 | 33644029 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 3.24e-06 | 289 | 49 | 6 | 23752268 | |
| Pubmed | 3.39e-06 | 653 | 49 | 8 | 33742100 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.70e-06 | 462 | 49 | 7 | 31138677 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DNAJB11 FAM120A AKAP8 STRAP RBBP4 CALU RBM10 CDC42 YWHAE HNRNPU | 3.79e-06 | 1149 | 49 | 10 | 35446349 |
| Pubmed | DNAJB11 NAMPT FAM120A AKAP8 STRAP RBBP4 CALU ELP1 YWHAE HNRNPU ITPR2 | 4.03e-06 | 1440 | 49 | 11 | 30833792 | |
| Pubmed | Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. | 5.83e-06 | 3 | 49 | 2 | 12482591 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 6.57e-06 | 327 | 49 | 6 | 15592455 | |
| Pubmed | 7.13e-06 | 723 | 49 | 8 | 34133714 | ||
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 7.77e-06 | 89 | 49 | 4 | 27034005 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DNAJB11 NAMPT AKAP8 STRAP RBBP4 UBE3A ELP1 DDX3Y YWHAE HNRNPU | 8.34e-06 | 1257 | 49 | 10 | 37317656 |
| Pubmed | 9.05e-06 | 346 | 49 | 6 | 25324306 | ||
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 1.14e-05 | 98 | 49 | 4 | 21942715 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 1.18e-05 | 210 | 49 | 5 | 26217791 | |
| Pubmed | 1.23e-05 | 212 | 49 | 5 | 23463506 | ||
| Pubmed | 1.32e-05 | 215 | 49 | 5 | 30462309 | ||
| Pubmed | FAM120A AKAP8 STRAP RBBP4 CPNE3 ELP1 DDX3Y CDC42 YWHAE HNRNPU | 1.41e-05 | 1335 | 49 | 10 | 29229926 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 1.41e-05 | 218 | 49 | 5 | 35831895 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.66e-05 | 582 | 49 | 7 | 20467437 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 24336796 | ||
| Pubmed | Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate. | 2.22e-05 | 116 | 49 | 4 | 27576135 | |
| Pubmed | 2.31e-05 | 613 | 49 | 7 | 22268729 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 2.37e-05 | 118 | 49 | 4 | 27377895 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 2.39e-05 | 1124 | 49 | 9 | 21900206 | |
| Pubmed | 2.42e-05 | 244 | 49 | 5 | 29884807 | ||
| Pubmed | 2.92e-05 | 1153 | 49 | 9 | 29845934 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 3.01e-05 | 639 | 49 | 7 | 23443559 | |
| Pubmed | 3.16e-05 | 432 | 49 | 6 | 7671812 | ||
| Pubmed | 3.23e-05 | 1168 | 49 | 9 | 19946888 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 3.47e-05 | 130 | 49 | 4 | 35545047 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FAM120A RBBP4 KIAA0232 SLC16A14 SIPA1L3 LAMA3 PALS2 YWHAE BRWD3 HNRNPU | 3.58e-05 | 1489 | 49 | 10 | 28611215 |
| Pubmed | 3.69e-05 | 660 | 49 | 7 | 32780723 | ||
| Pubmed | Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. | 4.07e-05 | 7 | 49 | 2 | 23001182 | |
| Pubmed | MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis. | 4.35e-05 | 48 | 49 | 3 | 37438558 | |
| Pubmed | 4.70e-05 | 464 | 49 | 6 | 32457219 | ||
| Pubmed | 4.89e-05 | 142 | 49 | 4 | 30217970 | ||
| Pubmed | 4.98e-05 | 469 | 49 | 6 | 27634302 | ||
| Pubmed | Comprehensive Proteomic Analysis of PGC7-Interacting Proteins. | 5.24e-05 | 287 | 49 | 5 | 28712289 | |
| Pubmed | 5.36e-05 | 1247 | 49 | 9 | 27684187 | ||
| Pubmed | 5.53e-05 | 963 | 49 | 8 | 28671696 | ||
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 5.67e-05 | 480 | 49 | 6 | 25437307 | |
| Pubmed | 5.86e-05 | 971 | 49 | 8 | 33306668 | ||
| Pubmed | Identification of differential protein interactors of lamin A and progerin. | 6.55e-05 | 55 | 49 | 3 | 21327095 | |
| Pubmed | 6.64e-05 | 494 | 49 | 6 | 26831064 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 6.71e-05 | 495 | 49 | 6 | 27705803 | |
| Pubmed | A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. | 6.96e-05 | 9 | 49 | 2 | 16728976 | |
| Pubmed | 7.02e-05 | 731 | 49 | 7 | 29298432 | ||
| Pubmed | 7.93e-05 | 1014 | 49 | 8 | 32416067 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 8.24e-05 | 316 | 49 | 5 | 31665637 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.01e-04 | 533 | 49 | 6 | 30554943 | |
| Pubmed | Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling. | 1.04e-04 | 332 | 49 | 5 | 29053956 | |
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 9427749 | ||
| Pubmed | Nudel binds Cdc42GAP to modulate Cdc42 activity at the leading edge of migrating cells. | 1.06e-04 | 11 | 49 | 2 | 18331715 | |
| Pubmed | 1.08e-04 | 174 | 49 | 4 | 35031058 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.10e-04 | 175 | 49 | 4 | 25756610 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.23e-04 | 344 | 49 | 5 | 36282215 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.24e-04 | 1082 | 49 | 8 | 38697112 | |
| Pubmed | The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping. | 1.27e-04 | 12 | 49 | 2 | 10495887 | |
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 12446789 | ||
| Pubmed | Dual-utility NLS drives RNF169-dependent DNA damage responses. | 1.27e-04 | 12 | 49 | 2 | 28325877 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.30e-04 | 807 | 49 | 7 | 30575818 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 1.38e-04 | 565 | 49 | 6 | 33567341 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.38e-04 | 353 | 49 | 5 | 27545878 | |
| Pubmed | 1.42e-04 | 187 | 49 | 4 | 29777862 | ||
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 1.48e-04 | 189 | 49 | 4 | 29449217 | |
| Pubmed | 1.50e-04 | 13 | 49 | 2 | 21029865 | ||
| Pubmed | 1.59e-04 | 74 | 49 | 3 | 29795351 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 1.59e-04 | 580 | 49 | 6 | 35676659 | |
| Pubmed | 1.65e-04 | 75 | 49 | 3 | 31527668 | ||
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 15570572 | ||
| Pubmed | 1.77e-04 | 1139 | 49 | 8 | 36417873 | ||
| Pubmed | 1.90e-04 | 378 | 49 | 5 | 34315543 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.93e-04 | 861 | 49 | 7 | 36931259 | |
| Pubmed | Nucleosome-interacting proteins regulated by DNA and histone methylation. | 2.02e-04 | 15 | 49 | 2 | 21029866 | |
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 30135474 | ||
| Pubmed | 2.02e-04 | 15 | 49 | 2 | 18303054 | ||
| Pubmed | 2.04e-04 | 1487 | 49 | 9 | 33957083 | ||
| Pubmed | 2.18e-04 | 878 | 49 | 7 | 37223481 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 2.29e-04 | 212 | 49 | 4 | 33462405 | |
| Pubmed | 2.30e-04 | 16 | 49 | 2 | 17137217 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.53e-04 | 1201 | 49 | 8 | 35696571 | |
| Pubmed | 2.61e-04 | 17 | 49 | 2 | 23281010 | ||
| Pubmed | A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. | 2.61e-04 | 17 | 49 | 2 | 24075985 | |
| Pubmed | 2.66e-04 | 638 | 49 | 6 | 33239621 | ||
| Interaction | TRIM28 interactions | DNAJB11 ZNF20 NAMPT AKAP8 STRAP RBBP4 UBE3A CPNE3 ELP1 UHRF1 DDX3Y PRMT3 CDC42 YWHAE HNRNPU | 1.25e-06 | 1474 | 49 | 15 | int:TRIM28 |
| Interaction | RAD18 interactions | 1.35e-06 | 457 | 49 | 9 | int:RAD18 | |
| Interaction | FBXW11 interactions | 1.79e-06 | 473 | 49 | 9 | int:FBXW11 | |
| Interaction | YAP1 interactions | FAM120A STRAP RBBP4 RBM10 SIPA1L3 CPNE3 UHRF1 CHD1 PRMT3 PPID YWHAE HNRNPU | 8.86e-06 | 1095 | 49 | 12 | int:YAP1 |
| Interaction | CCDC8 interactions | 2.49e-05 | 656 | 49 | 9 | int:CCDC8 | |
| Interaction | CEBPB interactions | DNAJB11 NAMPT AKAP8 STRAP RBBP4 CALU RBM10 ELP1 UHRF1 CDC42 YWHAE HCLS1 HNRNPU | 2.83e-05 | 1443 | 49 | 13 | int:CEBPB |
| Interaction | RBM39 interactions | DNAJB11 FAM120A AKAP8 STRAP RBBP4 CALU RBM10 SIPA1L3 CDC42 YWHAE HNRNPU | 3.19e-05 | 1042 | 49 | 11 | int:RBM39 |
| Interaction | PRKACA interactions | 3.27e-05 | 519 | 49 | 8 | int:PRKACA | |
| Interaction | CAPZB interactions | DNAJB11 FAM120A STRAP RBBP4 SIPA1L3 CHD1 PRMT3 CDC42 YWHAE HNRNPU ITPR2 | 3.39e-05 | 1049 | 49 | 11 | int:CAPZB |
| Interaction | ATG16L1 interactions | DNAJB11 FAM120A RBBP4 UBE3A CALU RBM10 SIPA1L3 ELP1 YWHAE HCLS1 ITPR2 | 8.50e-05 | 1161 | 49 | 11 | int:ATG16L1 |
| Interaction | ACTR3 interactions | 9.25e-05 | 305 | 49 | 6 | int:ACTR3 | |
| Interaction | GLDC interactions | 1.22e-04 | 321 | 49 | 6 | int:GLDC | |
| Interaction | RO60 interactions | 1.22e-04 | 200 | 49 | 5 | int:RO60 | |
| Interaction | DOT1L interactions | 1.23e-04 | 807 | 49 | 9 | int:DOT1L | |
| Interaction | RUFY1 interactions | 1.43e-04 | 476 | 49 | 7 | int:RUFY1 | |
| Interaction | ZFP36L2 interactions | 1.57e-04 | 211 | 49 | 5 | int:ZFP36L2 | |
| Interaction | U2AF2 interactions | 1.59e-04 | 651 | 49 | 8 | int:U2AF2 | |
| Interaction | TBC1D3F interactions | 1.61e-04 | 8 | 49 | 2 | int:TBC1D3F | |
| Interaction | BRCA1 interactions | DNAJB11 FAM120A AKAP8 ZNF280D STRAP RBBP4 UBE3A ANKRD26 UHRF1 YWHAE HNRNPU | 1.63e-04 | 1249 | 49 | 11 | int:BRCA1 |
| Interaction | GTSE1 interactions | 1.72e-04 | 215 | 49 | 5 | int:GTSE1 | |
| Interaction | CASP3 interactions | 1.75e-04 | 216 | 49 | 5 | int:CASP3 | |
| Interaction | HDLBP interactions | 1.90e-04 | 855 | 49 | 9 | int:HDLBP | |
| Interaction | ACO1 interactions | 1.91e-04 | 46 | 49 | 3 | int:ACO1 | |
| Interaction | MCM2 interactions | 2.29e-04 | 1081 | 49 | 10 | int:MCM2 | |
| Interaction | ARHGEF15 interactions | 2.30e-04 | 49 | 49 | 3 | int:ARHGEF15 | |
| Interaction | INS interactions | 2.43e-04 | 519 | 49 | 7 | int:INS | |
| Interaction | BCL2L14 interactions | 2.56e-04 | 127 | 49 | 4 | int:BCL2L14 | |
| Interaction | RAP1GAP interactions | 2.59e-04 | 51 | 49 | 3 | int:RAP1GAP | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-06 | 174 | 49 | 5 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-06 | 174 | 49 | 5 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 193 | 49 | 5 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 195 | 49 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 200 | 49 | 5 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 3.25e-05 | 165 | 49 | 4 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 5.07e-05 | 185 | 49 | 4 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.18e-05 | 186 | 49 | 4 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 189 | 49 | 4 | 73ee4cfb1057832f700be59b6917dedde3e89880 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 189 | 49 | 4 | a1bda6ed5c52a5d33d229018cb5982cae6305533 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.51e-05 | 189 | 49 | 4 | 31594cc59eb1c5b01407dfd72b1487ecca8bf5ec | |
| ToppCell | COVID-19_Mild-Lymphoid_P|COVID-19_Mild / Disease group, lineage and cell class | 5.51e-05 | 189 | 49 | 4 | 0b3d3bd697e79decae7e21c513fab9da3b2a47c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.51e-05 | 189 | 49 | 4 | c296660061b46e3abae1e7cf29df20274e5a8add | |
| ToppCell | COVID-19_Mild-Lymphoid_P-Plasmablast|COVID-19_Mild / Disease group, lineage and cell class | 5.51e-05 | 189 | 49 | 4 | 254f058850b41a5974a380f3710db7c01a51fb6b | |
| ToppCell | mild-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.51e-05 | 189 | 49 | 4 | db2097e6e165004d47ed504e115083a4e4f4b147 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.51e-05 | 189 | 49 | 4 | f2daf4889ef98bbefe3e44832618ac102a75b4d9 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.51e-05 | 189 | 49 | 4 | 9de17ade3cc3e9cd1394338bd048fb1ce64ac50f | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.63e-05 | 190 | 49 | 4 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.74e-05 | 191 | 49 | 4 | 73660d762c9d451980c21adc426db6670bcaf37f | |
| ToppCell | COVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class | 5.74e-05 | 191 | 49 | 4 | bb28703020c5296b65527094d2e5924348275e58 | |
| ToppCell | droplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | d9e61b2722aa81e4f6e11865a04f2f1e75b794ab | |
| ToppCell | COVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class | 5.86e-05 | 192 | 49 | 4 | 25c6c7a244190f82c7feab874bdec12490b7de4d | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 5.86e-05 | 192 | 49 | 4 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 5.86e-05 | 192 | 49 | 4 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | PBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 5.86e-05 | 192 | 49 | 4 | 385061d6257295bd515dea98f9bcd52374509276 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 5.86e-05 | 192 | 49 | 4 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.98e-05 | 193 | 49 | 4 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.98e-05 | 193 | 49 | 4 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.98e-05 | 193 | 49 | 4 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.98e-05 | 193 | 49 | 4 | 3ba6d44248690b80f4caf791d463e60f1ab816c4 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.98e-05 | 193 | 49 | 4 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 5.98e-05 | 193 | 49 | 4 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 193 | 49 | 4 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 193 | 49 | 4 | 8f57b0473a2c2c07f83e5fe70f16862b1bb3b514 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | severe-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.22e-05 | 195 | 49 | 4 | 43ff1eed563c647bc5b7b06ffe136210653c3a83 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.35e-05 | 196 | 49 | 4 | 455a2a1c98da413c8e9617b964b6ed141ed3a3be | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 196 | 49 | 4 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.47e-05 | 197 | 49 | 4 | d9a5b6171867de21d4ef12aa5a802fb4de9e0c00 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.47e-05 | 197 | 49 | 4 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.47e-05 | 197 | 49 | 4 | 2b58ac5d70e1ebd9bf9f2b60ee8079337a723658 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.60e-05 | 198 | 49 | 4 | 81c4c5377d0901ee9594424f08b0e4101686c850 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 6.73e-05 | 199 | 49 | 4 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-05 | 199 | 49 | 4 | d1a3eaef9e84d0572776e8468099d669b8a98ef7 | |
| ToppCell | 3'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-05 | 199 | 49 | 4 | 32ff62019535ea30059b63a2686c565baa54bfee | |
| ToppCell | 3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-05 | 199 | 49 | 4 | 7ff034b384f8fa4e027025aa5bf8cb856d793b18 | |
| ToppCell | 3'-Adult-Appendix-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-05 | 199 | 49 | 4 | 77bdd3df106c05acc173555ce13243d93c50e94d | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast|COVID-19_Mild / Disease, condition lineage and cell class | 6.73e-05 | 199 | 49 | 4 | 46f31aef26c3da7608082f750d743ad54adbc51a | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 78a9b26215874a46a910a4b93a51fcac1a597618 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-05 | 199 | 49 | 4 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 200 | 49 | 4 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.86e-05 | 200 | 49 | 4 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | severe_influenza-B_cell|World / disease group, cell group and cell class (v2) | 1.17e-04 | 86 | 49 | 3 | 7b595bcba4bcb72b7de7c06e19f690f0c739c529 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(2)_48hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 1.76e-04 | 18 | 49 | 2 | 80d5417681a700e289025f3657bfabbb0abcf043 | |
| ToppCell | severe_influenza-B_cell|severe_influenza / disease group, cell group and cell class (v2) | 3.77e-04 | 128 | 49 | 3 | 92b250186d6bb08ce4f2f5cc4fb93928f6b92d3a | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_only / Treatment groups by lineage, cell group, cell type | 4.69e-04 | 138 | 49 | 3 | 6ddd50e44a3914596b4cd61ae64a987119fe7979 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 139 | 49 | 3 | b07929348ec9ad95d7bce33a7deac0938227b19f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.10e-04 | 142 | 49 | 3 | 8b5441d0564e67ab4db58d9082909b5dab430a28 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 5.87e-04 | 149 | 49 | 3 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.98e-04 | 150 | 49 | 3 | c2c51a3230c978e2fdb1b3ae14193d4014431b25 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.33e-04 | 153 | 49 | 3 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Neuronal-Cortical_neuron|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.38e-04 | 34 | 49 | 2 | 6c9c477b43009cded5a2e1a1792c32c40d9309a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-04 | 154 | 49 | 3 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 6.70e-04 | 156 | 49 | 3 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-04 | 157 | 49 | 3 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.83e-04 | 157 | 49 | 3 | 10341ed8cbee0f636770a82cf580f6453bee8596 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.08e-04 | 159 | 49 | 3 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.08e-04 | 159 | 49 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.08e-04 | 159 | 49 | 3 | a5fee9e7ee00c20a4ba30b0dfaf1189fb109a1af | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.21e-04 | 160 | 49 | 3 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.21e-04 | 160 | 49 | 3 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.21e-04 | 160 | 49 | 3 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 7.34e-04 | 161 | 49 | 3 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, Lineage and Cell Type | 7.34e-04 | 161 | 49 | 3 | bcd122af09cbb99d1816200d9c367af8b7f36873 | |
| ToppCell | 10x5'-blood-Lymphocytic_B-ABC_aged-B_memory|blood / Manually curated celltypes from each tissue | 7.75e-04 | 164 | 49 | 3 | 0424b23fc540580e7c15c50a7a03dff7c25014fa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.75e-04 | 164 | 49 | 3 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.88e-04 | 165 | 49 | 3 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-04 | 167 | 49 | 3 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-04 | 167 | 49 | 3 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-04 | 167 | 49 | 3 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 8.45e-04 | 169 | 49 | 3 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 170 | 49 | 3 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 170 | 49 | 3 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 170 | 49 | 3 | 4ab2a890c8631028ee9099d2faf6091c742a317b | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-04 | 170 | 49 | 3 | 6686d1797988216c0d9417f21a2537369abce410 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.74e-04 | 171 | 49 | 3 | 1018d7bd378ce20bee56a77d5851b3538c55098c | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.74e-04 | 171 | 49 | 3 | 6bda333bb751d7835a04f21ac959eea79f2516aa | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 8.74e-04 | 171 | 49 | 3 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.74e-04 | 171 | 49 | 3 | 173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 8.74e-04 | 171 | 49 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-04 | 172 | 49 | 3 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-04 | 172 | 49 | 3 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | droplet-Spleen-SPLEEN|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-04 | 172 | 49 | 3 | d32731a56e113ff0ef7167b23959d69baf2068f9 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 9.04e-04 | 173 | 49 | 3 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 9.19e-04 | 174 | 49 | 3 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.19e-04 | 174 | 49 | 3 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| Computational | Neighborhood of TYK2 | 1.48e-04 | 33 | 34 | 3 | GNF2_TYK2 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.67e-04 | 75 | 49 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 3.48e-04 | 82 | 49 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.48e-04 | 82 | 49 | 3 | C0751111 | |
| Disease | Aura | 3.48e-04 | 82 | 49 | 3 | C0236018 | |
| Disease | Epilepsy | 7.98e-04 | 109 | 49 | 3 | C0014544 | |
| Disease | age at first birth measurement | 1.05e-03 | 120 | 49 | 3 | EFO_0009101 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFYYGKHEGDVQEEQ | 301 | Q6N043 | |
| GDYHRYLAEFATGND | 126 | P62258 | |
| SYDYEFDLGSDRNGS | 151 | O43823 | |
| DSVFKNYDHDQDGYI | 476 | O95267 | |
| KVECYDYDNDGSHDL | 211 | O75131 | |
| TDQDYVDGDHDYSKF | 1631 | Q6RI45 | |
| EEYIGDMYSHDGNTD | 211 | O43852 | |
| EYENGEFSFHGDLKT | 1376 | Q9UPS8 | |
| FEEEHGKGREYGYAS | 671 | O14646 | |
| GYDDDNHDYIVRSGE | 91 | Q9Y463 | |
| REYGSQEGKHDYDDS | 46 | P98175 | |
| DGGRYTFEDAQEHIY | 416 | P49758 | |
| DPDEGDEALKYYANH | 2131 | Q14571 | |
| GYFYHGLNLDDGKED | 561 | Q6IE37 | |
| GQYTHEFDGDEEFYV | 46 | P01906 | |
| DEDGYTAADLAEYHG | 301 | Q6ZVH7 | |
| EESDKNYFEGTGYAR | 2596 | Q16787 | |
| KDGFQDGYGTETYSD | 111 | Q96JJ6 | |
| EEDGRYSVDYSKFGN | 321 | Q14654 | |
| NASYSYEGDEHGDTE | 746 | P51805 | |
| EDAEKEGHYYGKSEL | 1156 | Q92628 | |
| YLAEKGENDHFDTYA | 251 | O43526 | |
| EDHGRGYFEYIEENK | 251 | Q00839 | |
| DVNELYDHSLGTYDF | 886 | O95163 | |
| YTLGLFDTAGQEDYD | 51 | P60953 | |
| ENGFHGLVAYDSDYA | 176 | Q9NZB2 | |
| AQFDASHYDSEKGEF | 91 | Q09028 | |
| EHGEYEGNLYGTKID | 406 | Q9NZW5 | |
| DLQEDEDGVYFSSYG | 211 | O60678 | |
| YDTYGEEGLKDGHQS | 86 | Q9UBS4 | |
| YEEVFKEGNEGHDLY | 406 | Q8N7U6 | |
| HGLSEETYDSYGQEE | 306 | O75525 | |
| GADSLEDFLYHEGYA | 451 | O15523 | |
| GPIFDYDYDGLHDTE | 736 | Q13822 | |
| DGSKNFDGFHAIYEE | 221 | Q6UXH9 | |
| GQLHKAEGEYSDGYR | 41 | Q9NUT2 | |
| AALGYDYKGETEKHE | 171 | P14317 | |
| VYDYQGEGSDELSFD | 436 | P14317 | |
| MYTSHEDIGYDFEDG | 1 | Q7RTX9 | |
| ESIYGEKFEDENFHY | 96 | Q08752 | |
| EEEGDGSDHPYYNSI | 331 | Q92529 | |
| DYFVGKEHANYFGVD | 506 | O60292 | |
| GNLDGLEYKLHDFGY | 181 | P43490 | |
| KDYIGDDSHFYVLDG | 316 | Q9NY46 | |
| DYNSGEELESYKGHF | 251 | Q9Y3F4 | |
| ADTGHKSSEYQEYGE | 126 | P17024 | |
| DFQALEETTEYDGGY | 766 | Q05086 | |
| KGHENEESAYYSDLF | 196 | Q02094 | |
| YEDDVDHGNFFTYTG | 466 | Q96T88 | |
| DSVGKQHSEYEYGND | 346 | Q9UL58 | |
| AGGHYIYLEADEFSQ | 416 | Q9Y493 |